QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden RegionsBusiness Wire • 10/19/21
QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDxBusiness Wire • 09/30/21
QIAGEN Reaches Milestone With Its Kits Used to Process More Than Three Billion Biological Samples to DateBusiness Wire • 08/23/21
QIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR TechnologyBusiness Wire • 08/10/21
Qiagen Inks Companion Diagnostic Development, Technology-Licensing Deal With OncXernaBenzinga • 08/10/21
QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic AgreementsBusiness Wire • 08/09/21
QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigenBusiness Wire • 08/06/21
Qiagen (QGEN) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 07/22/21
Qiagen Stock Drops After Trimming FY21 Earnings Forecast On Weaker COVID-19 Testing TrendsBenzinga • 07/12/21
QIAGEN N.V. Conference Call on July 13 to Discuss Preliminary Q2 2021 ResultsBusiness Wire • 07/12/21